TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01515605 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT01515605 — Predictive Biomarker (PRD): ISG15 mRNA
Genes: ISG15; G1P2; UCRP
Study NCT01515605 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT01515605 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT01204034 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01712685 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT01795352 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01795352 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03499353 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03499353 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02937844 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02937844 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02937844 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03656757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00973219 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06303830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02788136 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT04289285 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02286362 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03419247 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT03419247 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT03154086 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT03135314 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04340674 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT01246687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02187783 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02620137 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01731457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01731457 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01731457 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT01731457 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01731457 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01731457 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study NCT01731457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01731457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01731457 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03073798 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01496430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02353936 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02355730 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06216015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04032808 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04541355 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01079455 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00171301 — Predictive Biomarker (PRD): Liver iron
Study NCT02716311 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02716311 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02637921 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02637921 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04222816 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03413202 — Predictive Biomarker (PRD): NUBP1 mRNA
Genes: NUBP1; NBP; NBP1
Study NCT03304223 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01949805 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03262051 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03262051 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03262051 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00006322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03676634 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04185857 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03848195 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03914300 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03049631 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT04390646 — Predictive Biomarker (PRD): GNRHR mRNA
Genes: GNRHR; GRHR
Study NCT04309968 — Predictive Biomarker (PRD): BRD4 mRNA
Genes: BRD4; HUNK1
Study NCT02805166 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00108043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03425747 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03480880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00409240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01750294 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01534845 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01534845 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01146223 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT01602328 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01515163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02991196 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT02991196 — Predictive Biomarker (PRD): TNFRSF10B mRNA
Genes: TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; UNQ160/PRO186
Study NCT03169829 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01165047 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04185363 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT02378389 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02378389 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04366544 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04366544 — Safety Biomarker (SAF): BDNF
Study NCT01334294 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01124786 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study NCT04286542 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01000701 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT01000701 — Predictive Biomarker (PRD): SP2 mRNA
Genes: SP2; KIAA0048
Study NCT01000701 — Predictive Biomarker (PRD): SP3 mRNA
Genes: SP3
Study NCT01000701 — Predictive Biomarker (PRD): SP5 mRNA
Genes: SP5
Study NCT01206803 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01283503 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01098903 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT01098903 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study NCT01098903 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT00844935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01438593 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04362293 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02984982 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02984982 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04605211 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04605211 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00512239 — Predictive Biomarker (PRD): RASA1 mRNA
Genes: RASA1; GAP; RASA
Study NCT02481050 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02481050 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03044210 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04798703 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00349765 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00349765 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00807495 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT02731781 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT00591747 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01994733 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01229150 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00293462 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03393520 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01458067 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01265498 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT00902538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00632190 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04200716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02395068 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02395068 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02117167 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03158077 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT02383524 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02383524 — Safety Biomarker (SAF): BDNF
Study NCT00166660 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT03268135 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study NCT01351610 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04298086 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04298086 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00004933 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00004933 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03050359 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02370355 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03898869 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02570828 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT02559843 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03694197 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03694197 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00712855 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT03082209 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT02438735 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03774329 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02484807 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03895879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04334863 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04334863 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02457260 — Predictive Biomarker (PRD): SIRT3 mRNA
Genes: SIRT3; SIR2L3
Study NCT02469363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04365439 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03591276 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03591276 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03591276 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03591276 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03987295 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT00393276 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01562613 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01685255 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01121419 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT01121419 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01127087 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT03578497 — Safety Biomarker (SAF): Interleukin 1
Study NCT04040517 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT01338324 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03717103 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT00535912 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02589483 — Predictive Biomarker (PRD): RORA mRNA
Genes: RORA; NR1F1; RZRA
Study NCT05815134 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03669250 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT03669250 — Pharmacodynamic Biomarker (PDY): Auditory mismatch negativity
Study NCT02817503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04756921 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04756921 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02550535 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02550535 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02974907 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study NCT02725580 — Predictive Biomarker (PRD): CLN6 mRNA
Genes: CLN6
Study NCT02804724 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01470430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01470430 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01293162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04308616 — Predictive Biomarker (PRD): SERPINB3 mRNA
Genes: SERPINB3; SCCA; SCCA1
Study NCT01113853 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00961376 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00961376 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02883543 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03524716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00874276 — Predictive Biomarker (PRD): GSTZ1 mRNA
Genes: GSTZ1; MAAI
Study NCT03909165 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04143880 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03040401 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study NCT03040401 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02420353 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT00171015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02632253 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04045158 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04619368 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04212390 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT02637141 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT01783535 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT00909038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04143607 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02623257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02623257 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02623257 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01566435 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT03005366 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study NCT02988258 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02047305 — Predictive Biomarker (PRD): SERPINB3 mRNA
Genes: SERPINB3; SCCA; SCCA1
Study NCT01181284 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01181284 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01171768 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01171768 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01171768 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT02527213 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01624272 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01924247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03306277 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04020796 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03176381 — Predictive Biomarker (PRD): HOXB3 mRNA
Genes: HOXB3; HOX2G
Study NCT03176381 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT03176381 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT03176381 — Predictive Biomarker (PRD): YAP1 mRNA
Genes: YAP1; YAP65
Study NCT03176381 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT00687206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03056144 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02291796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04254133 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04254133 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04254133 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT01100814 — Predictive Biomarker (PRD): S100A2 mRNA
Genes: S100A2; S100L
Study NCT01100814 — Predictive Biomarker (PRD): TFF1 mRNA
Genes: TFF1; BCEI; PS2
Study NCT04114396 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03061591 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06321653 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT02524691 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02713997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00670982 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01957059 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01957059 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT02256943 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02741687 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02705573 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02705573 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02705573 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02705573 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT02705573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02705573 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02705573 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02705573 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03393780 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01581047 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04007939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00199654 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03789110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04917991 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03843294 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00002890 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT01159145 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03552328 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05751447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03862547 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04394624 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01296529 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03103360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01983735 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01883960 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04469751 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03213041 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL